Literature DB >> 12271796

Distinguishing characteristics of subjects with good and poor early outcome in the Edinburgh High-Risk Study.

Eve C Johnstone1, Richard Cosway, Stephen M Lawrie.   

Abstract

BACKGROUND: 'High-risk' studies of schizophrenia have the potential to clarify the pathogenesis of schizophrenia. Here, results of extreme outcome groups in the Edinburgh High-Risk Study are presented. AIMS: To compare groups of good and poor outcome from the Edinburgh High-Risk Study and clarify the nature of the change from the state of vulnerability to that of developing psychosis.
METHOD: The recruitment procedure is described. Good and poor outcome are defined. These groups are compared in terms of genetic liability and of baseline and change in neuropsychology and neuroanatomy.
RESULTS: Demographic characteristics and genetic liability do not differ between the groups. The good outcome group perform better at baseline in some neuropsychological tests, but there is little neuroanatomical difference. The poor outcome group show consistently impaired memory function and a tendency to reduction in temporal lobe size.
CONCLUSIONS: In genetically predisposed subjects, the change from vulnerability to developing psychosis may be marked by a reduced size and impaired function of the temporal lobe.

Entities:  

Mesh:

Year:  2002        PMID: 12271796     DOI: 10.1192/bjp.181.43.s26

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  4 in total

1.  The Edinburgh High Risk Study: current status and future prospects.

Authors:  Eve C Johnstone; Kirsten D Russell; Lesley K Harrison; Stephen M Lawrie
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

2.  Progressive alterations of the auditory association areas in young non-psychotic offspring of schizophrenia patients.

Authors:  Tejas S Bhojraj; John A Sweeney; Konasale M Prasad; Shaun Eack; Rajaprabhakaran Rajarethinam; Alan N Francis; Debra M Montrose; Matcheri S Keshavan
Journal:  J Psychiatr Res       Date:  2010-06-11       Impact factor: 4.791

Review 3.  Cognitive control deficits in schizophrenia: mechanisms and meaning.

Authors:  Tyler A Lesh; Tara A Niendam; Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

Review 4.  Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk.

Authors:  Stephen M Lawrie; Andrew M McIntosh; Jeremy Hall; David G C Owens; Eve C Johnstone
Journal:  Schizophr Bull       Date:  2008-01-27       Impact factor: 9.306

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.